Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |